A detailed history of Financial Engines Advisors L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Engines Advisors L.L.C. holds 1,649 shares of LLY stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,649
Previous 1,497 10.15%
Holding current value
$1.31 Million
Previous $1.36 Million 7.75%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $117,365 - $145,923
152 Added 10.15%
1,649 $1.46 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $57,264 - $71,814
79 Added 5.57%
1,497 $1.36 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $108,964 - $145,779
184 Added 14.91%
1,418 $1.1 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $102,937 - $121,349
196 Added 18.88%
1,234 $719,000
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $86,070 - $118,661
198 Added 23.57%
1,038 $557,000
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $6,313 - $8,441
18 Added 2.19%
840 $393,000
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $465,013 - $546,135
-1,497 Reduced 64.55%
822 $282,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $42,123 - $49,081
131 Added 5.99%
2,319 $848,000
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $209,611 - $238,874
-707 Reduced 24.42%
2,188 $707,000
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $213,228 - $250,361
765 Added 35.92%
2,895 $938,000
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $499,889 - $621,235
2,130 New
2,130 $610,000
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $411,475 - $510,643
-1,830 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $80,884 - $99,539
365 Added 24.91%
1,830 $422,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $10,471 - $13,545
58 Added 4.12%
1,465 $336,000
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $13,474 - $17,443
82 Added 6.19%
1,407 $263,000
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $33,267 - $44,020
-255 Reduced 16.14%
1,325 $224,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $231,027 - $267,225
1,580 New
1,580 $234,000
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $6,248 - $6,999
-59 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$85.86 - $107.31 $5,065 - $6,331
59 New
59 $6,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Financial Engines Advisors L.L.C. Portfolio

Follow Financial Engines Advisors L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.